Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. United States
  4. Nasdaq
  5. Moderna, Inc.
  6. News
  7. Summary
    MRNA   US60770K1079

MODERNA, INC.

(MRNA)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector newsMarketScreener Strategies

Moderna : U.S. administers nearly 412 mln doses of COVID-19 vaccines - CDC

10/22/2021 | 03:48pm EST

Oct 22 (Reuters) - The United States has administered 411,963,025 doses of COVID-19 vaccines in the country as of Friday morning and distributed 501,613,665 doses, the U.S. Centers for Disease Control and Prevention said.

Those figures are up from the 411,010,650 vaccine doses the CDC said had gone into arms by Thursday out of 498,702,405 doses delivered.

The agency said 219,900,525 people had received at least one dose, while 190,179,553 people are fully vaccinated as of 6:00 a.m. ET on Friday.

The CDC tally includes two-dose vaccines from Moderna and Pfizer/BioNTech , as well as Johnson & Johnson's one-shot vaccine.

About 12 million people received a booster dose of either Pfizer or Moderna's vaccine since Aug. 13, when the United States authorized a third dose of the vaccines for people with compromised immune systems who are likely to have weaker protection from the two-dose regimens. (Reporting by Ruhi Soni in Bengaluru; Editing by Maju Samuel)


© Reuters 2021
All news about MODERNA, INC.
04:34aWith new Omicron case detected, UK awaits COVID booster advice
RE
11/26Vaccine companies testing efficacy against COVID-19 Omicron variant
AQ
11/26Moderna to Test Variant-Specific Vaccine Candidate
DJ
11/26Moderna Announces Strategy to Address Omicron (B.1.1.529) SARS-CoV-2 Variant
BU
11/26ADRs Close Lower; BioNTech Rises, Carnival Drops
DJ
11/26US Stocks, Treasury Yields Sink With Crude Oil as Concern Mounts Over New COVID-19 Stra..
MT
11/26CLOSE UPDATE : US Stocks, Treasury Yields Sink With Crude Oil as Concern Mounts Over New C..
MT
11/26Delta, Carnival fall; Moderna, Clorox rise
AQ
11/26Stocks tumble on new coronavirus variant fear
RE
11/26Covid-19 Vaccine Maker Stocks Higher Amid Variant Concerns
DJ
More news
Analyst Recommendations on MODERNA, INC.
More recommendations
Financials (USD)
Sales 2021 17 449 M - -
Net income 2021 11 170 M - -
Net cash 2021 12 747 M - -
P/E ratio 2021 12,5x
Yield 2021 -
Capitalization 134 B 134 B -
EV / Sales 2021 6,93x
EV / Sales 2022 5,38x
Nbr of Employees 1 300
Free-Float 90,5%
Chart MODERNA, INC.
Duration : Period :
Moderna, Inc. Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends MODERNA, INC.
Short TermMid-TermLong Term
TrendsNeutralNeutralBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus HOLD
Number of Analysts 18
Last Close Price 329,63 $
Average target price 272,53 $
Spread / Average Target -17,3%
EPS Revisions
Managers and Directors
Stéphane Bancel Chief Executive Officer & Director
Stephen Hoge President
David W. Meline Chief Financial Officer
Noubar B. Afeyan Chairman
Juan Andres Chief Technical Operations & Quality Officer
Sector and Competitors
1st jan.Capi. (M$)
MODERNA, INC.215.53%133 648
LONZA GROUP AG29.85%59 443
IQVIA HOLDINGS INC.46.26%50 064
SEAGEN INC.-3.22%30 994
CELLTRION, INC.-40.39%24 431
ALNYLAM PHARMACEUTICALS, INC.45.06%22 548